Follow The Filings

REX

Earnings company data as of 4:49 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 3 Dec EPS — — —
Rev — — —
FY2026 Q2 2 Sep EPS — 1.06 —
Rev — $168.5M —

Insider trades

Open-market buys and sales by REX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All REX insider trades
  • None no insider bought on the open market
  • $7.1M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Stuart A Rose Executive COB
    Sale
    $2.1M 50,000 shares at $42.55 2.1% of stake
    Traded Sep 30 Filed Oct 1
    ↗
  2. Stuart A Rose Executive COB
    Sale
    $663K 15,186 shares at $43.64 2.6% of stake
    Traded Jun 18 Filed Jun 22
    ↗
  3. Stuart A Rose Executive COB
    Sale
    $3M 69,335 shares at $43.77 11% of stake
    Traded Jun 17 Filed Jun 18
    ↗
  4. Stuart A Rose Executive COB
    Sale
    $34K 766 shares at $44.14 0.1% of stake
    Traded Jun 11 Filed Jun 15
    ↗
  5. Stuart A Rose Executive COB
    Sale
    $50K 1,129 shares at $44.52 0.2% of stake
    Traded Jun 10 Filed Jun 11
    ↗
  6. Stuart A Rose Executive COB
    Sale
    $614K 13,584 shares at $45.23 2.1% of stake
    Traded Jun 8 Filed Jun 10
    ↗
  7. Douglas Bruggeman CFO
    Sale
    $248K 5,086 shares at $48.73 2% of stake
    Traded Jun 2 Filed Jun 3
    ↗
  8. Douglas Bruggeman CFO
    Sale
    $91K 2,000 shares at $45.44 0.8% of stake
    Traded Apr 2 Filed Apr 3
    ↗
  9. Douglas Bruggeman CFO
    Sale
    $227K 5,000 shares at $45.41 1.9% of stake
    Traded Mar 31 Filed Apr 1
    ↗

Also filed in the last 12 months, not counted as buying or selling: 20 stock grants, 3 gifts, 2 share withholdings for taxes, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Period Jul 31, 2026 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
10-Q Period Apr 30, 2026 Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Period May 28, 2026 Filing Doc
DEFA14A — Filing Doc
10-K Period Jan 31, 2026 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Period Oct 31, 2025 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.